Details for Patent: 6,465,477
✉ Email this page to a colleague
Summary for Patent: 6,465,477
Title: | Stable pharmaceutical composition |
Abstract: | Disclosed is a pharmaceutical composition comprising (E)-3,5-dihydroxy-7-[4'-4"-fluorophenyl-2'-cyclopropyl-quinolin-3'-yl]-6-h eptenoic acid, or its salt or ester, of which the aqueous solution or dispersion has pH of from 6.8 to 8. The composition has good time-dependent stability and has no change in its outward appearance even after having been stored long. |
Inventor(s): | Muramatsu; Toyojiro (Shizuoka, JP), Mashita; Katsumi (Fuji, JP), Shinoda; Yasuo (Shizuoka, JP), Sassa; Hironori (Numazu, JP), Kawashima; Hiroyuki (Fuji, JP), Tanizawa; Yoshio (Okayama, JP), Takeuchi; Hideatsu (Fuji, JP) |
Assignee: | Kowa Company, Ltd. (Aichi-Ken, JP) Nissan Chemical Industries, Ltd. (Tokyo, JP) |
Application Number: | 09/436,789 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 6,465,477 |
Patent Claim Types: see list of patent claims | Composition; Formulation; Dosage form; |
Drugs Protected by US Patent 6,465,477
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |